Shoulder Innovations (NYSE:SI) COO Sells $78,072.96 in Stock

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 4,144 shares of the firm’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $18.84, for a total value of $78,072.96. Following the completion of the sale, the chief operating officer directly owned 269,176 shares in the company, valued at approximately $5,071,275.84. The trade was a 1.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.68, for a total value of $296,190.08.

Shoulder Innovations Price Performance

Shares of NYSE:SI traded up $0.66 on Tuesday, hitting $18.78. The company’s stock had a trading volume of 165,354 shares, compared to its average volume of 81,765. The company has a 50-day simple moving average of $14.56 and a 200 day simple moving average of $14.38. Shoulder Innovations, Inc. has a 1 year low of $10.92 and a 1 year high of $19.79. The company has a market capitalization of $389.43 million and a PE ratio of -0.11. The company has a debt-to-equity ratio of 0.11, a current ratio of 11.81 and a quick ratio of 10.04.

Shoulder Innovations (NYSE:SI) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.03. The firm had revenue of $16.71 million for the quarter. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%. Sell-side analysts forecast that Shoulder Innovations, Inc. will post -1.67 EPS for the current fiscal year.

Hedge Funds Weigh In On Shoulder Innovations

A number of large investors have recently modified their holdings of SI. Sectoral Asset Management Inc. grew its position in Shoulder Innovations by 14.4% during the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock worth $7,042,000 after acquiring an additional 62,153 shares during the last quarter. Deerfield Management Company L.P. bought a new position in Shoulder Innovations during the 3rd quarter worth approximately $6,056,000. Alyeska Investment Group L.P. bought a new position in Shoulder Innovations during the 3rd quarter worth approximately $5,667,000. TimesSquare Capital Management LLC bought a new position in Shoulder Innovations during the 3rd quarter worth approximately $4,799,000. Finally, Roubaix Capital LLC grew its position in Shoulder Innovations by 61.9% during the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after acquiring an additional 98,305 shares during the last quarter.

Wall Street Analyst Weigh In

SI has been the topic of a number of research reports. BTIG Research raised their price objective on Shoulder Innovations from $23.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, March 11th. Piper Sandler reissued an “overweight” rating and set a $19.00 price objective (up from $18.00) on shares of Shoulder Innovations in a report on Friday, May 8th. Five investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Shoulder Innovations currently has an average rating of “Moderate Buy” and an average price target of $21.00.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.